# EDGAR Filing Document

**Accession Number:** 0001485003
**File Stem:** 0001213900-25-079448
**Filing Date:** 2025-8
**Character Count:** 8877
**Document Hash:** 8c7f2db9ecbe1cf11c6be72872501c20
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-079448.hdr.sgml**: 20250821

**ACCESSION NUMBER**: 0001213900-25-079448

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250821

**DATE AS OF CHANGE**: 20250821

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Carisma Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0001485003
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 262025616
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-87951
- **FILM NUMBER:** 251241833

**BUSINESS ADDRESS:**
- **STREET 1:** 3675 MARKET STREET
- **STREET 2:** SUITE 401
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104
- **BUSINESS PHONE:** 2674916422

**MAIL ADDRESS:**
- **STREET 1:** 3675 MARKET STREET
- **STREET 2:** SUITE 401
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19104

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sesen Bio, Inc.
- **DATE OF NAME CHANGE:** 20180516

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Eleven Biotherapeutics, Inc.
- **DATE OF NAME CHANGE:** 20100223
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HealthCap VII, L.P.
- **CENTRAL INDEX KEY:** 0001645161

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 18 AVENUE D'OUCHY
- **CITY:** CH 1006 LAUSANNE
- **STATE:** V8
- **ZIP:** 1000-1018
- **BUSINESS PHONE:** 41 21 614 3500

**MAIL ADDRESS:**
- **STREET 1:** 18 AVENUE D'OUCHY
- **CITY:** CH 1006 LAUSANNE
- **STATE:** V8
- **ZIP:** 1000-1018

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 4)**

**Carisma Therapeutics Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.001 per share**

*(Title of Class of Securities)*

**14216R101**

*(CUSIP Number)*

**HealthCap VII, L.P.**<br>Represented by HealthCap Investments SA<br>23 Avenue Villamont<br>Lausanne V8 CH-1005<br>4121 614 3500

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/19/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **14216R101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**HealthCap VII, L.P.** | Name of reporting person<br>**HealthCap VII, L.P.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**2721923.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**2721923.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2721923.00** | Aggregate amount beneficially owned by each reporting person<br>**2721923.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.5%** | Percent of class represented by amount in Row (11)<br>**6.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **14216R101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**HealthCap VII GP LLC** | Name of reporting person<br>**HealthCap VII GP LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**2721923.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**2721923.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**2721923.00** | Aggregate amount beneficially owned by each reporting person<br>**2721923.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**6.5%** | Percent of class represented by amount in Row (11)<br>**6.5%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.001 per share

**(b) Name of Issuer:**
Carisma Therapeutics Inc.

**(c) Address of Issuer's Principal Executive Offices:**
3675 Market Street, Suite 401, Philadelphia, PA, 19104

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on approximately 41,788,096 shares of Common Stock outstanding as of August 5, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on August 7, 2024.

**(b)**
The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference.

**(c)**
The Reporting Persons have effected the following transactions related to the Common Stock during the past 60 days:

Sold 39,100 shares of Common Stock on August 13, 2025 at a price of $0.289 per share; sold 81,003 shares of Common Stock on August 14, 2025 at a price of $0.284 per share; sold 50,402 shares of Common Stock on August 15, 2025 at a price of $0.284 per share; sold 72,617 shares of Common Stock on August 18, 2025 at a price of $0.28 per share; sold 184,500 shares of Common Stock on August 19, 2025 at a price of $0.247 per share; sold 134,000 shares of Common Stock on August 20, 2025 at a price of $0.228 per share; and sold 114,403  shares of Common Stock on August 21, 2025 at a price of $0.228 per share.

Except as set forth above, the Reporting Person has not effected any transactions related to the Common Stock during the past 60 days.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** HealthCap VII, L.P.

**Signature:** /s/ Dag Richter

**Name/Title:** By: HealthCap VII GP LLC, its general partner; By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director

**Date:** 08/21/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** HealthCap VII GP LLC

**Signature:** /s/ Dag Richter

**Name/Title:** By: HealthCap Investments SA, its investment manager; By: Dag Richter, Director

**Date:** 08/21/2025